Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2018 01:30 ET | Source: Sensorion

Sensorion Presents Three Posters At The 55th Inner Ear Biology Workshop

MONTPELLIER, France, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today presented three posters at the...
September 03, 2018 01:30 ET | Source: Sensorion

Sensorion Announces Three Poster Presentations At The 55th Inner Ear Biology Workshop

MONTPELLIER, France, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present three posters at the...
August 20, 2018 01:30 ET | Source: Sensorion

Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss

Sensorion’s 2nd European Voluntary Harmonization Procedure Application Approval International Multicenter Phase 2 with SENS-401 for Treating Sudden Sensorineuronal Hearing Loss in Adults to Start ...
July 24, 2018 01:30 ET | Source: Sensorion

Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance

Safety and pharmacodynamic effects of seliforant compared to meclizine MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the...
June 29, 2018 01:30 ET | Source: Sensorion

Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models

MONTPELLIER, France, June 29, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, presented data showing that its...
June 06, 2018 01:30 ET | Source: Sensorion

Sensorion Announces Oral Presentation at the 15th International Conference on Cochlear Implants and Other Implantable Auditory Technologies (Ci2018)

The company will present preclinical data on the otoprotective capacity of SENS-401 which may benefit cochlear implant patients MONTPELLIER, France, June 06, 2018 (GLOBE NEWSWIRE) -- Sensorion...
June 04, 2018 11:35 ET | Source: Sensorion

Sensorion’s Chair of Scientific Advisory Board, Prof. Christine Petit, Awarded 2018 Kavli Prize in Neuroscience

Christine Petit, A. James Hudspeth, and Robert Fettiplace recognized for their pioneering work on the molecular and neural mechanisms of hearing. MONTPELLIER, France, June 04, 2018 (GLOBE NEWSWIRE)...
June 01, 2018 11:35 ET | Source: Sensorion

Sensorion to Present at the 2018 BIO International Convention

MONTPELLIER, France, June 01, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present at the 25th BIO...
May 22, 2018 01:30 ET | Source: Sensorion

Sensorion Appoints Professor Christine Petit, MD, PhD as Chair of its Scientific Advisory Board

Internationally-renowned geneticist and neurobiologist with decades of hearing research leadership to head Sensorion’s Scientific Advisory Board MONTPELLIER, France, May 22, 2018 (GLOBE NEWSWIRE)...
May 03, 2018 01:30 ET | Source: Sensorion

World Health Organization Grants Name ‘Seliforant’ to Sensorion’s SENS-111 Treatment

Seliforant (formerly SENS-111) is a first-in-class histamine H4 receptor antagonist candidate selected for the treatment of vertigo of vestibular origin, in development to treat acute unilateral...